Not applicableStudy completedNCT04090164What this trial is testingAssociation of Hepatitis C Virus With Breast CancerWho this might be right forBreast CancerHepatitis C Mansoura University 650
Testing effectiveness (Phase 2)UnknownNCT02175446What this trial is testingSafety and Efficacy Study of Eribulin in Combination With Bevacizumab for Second-line Treatment HER2- MBC PatientsWho this might be right forMetastatic Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast Consorzio Oncotech 61
Post-approval studies (Phase 4)UnknownNCT03270007What this trial is testingResearch of Intensive Treatment in Hormone Receptor<10% and Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer Patients With Positive Lymph Node Residual Disease After Neoadjuvant ChemotherapyWho this might be right forPrimary Breast Cancer Tao OUYANG 304
Early research (Phase 1)Active Not RecruitingNCT02826434What this trial is testingAdjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast CancerWho this might be right forBreast Cancer Massachusetts General Hospital 22
Not applicableStudy completedNCT03829306What this trial is testingUnraveling KAdcyla Resistance In Human Epidermal Growth Factor Receptor 2(HER2) Positive Advanced Breast Cancer (KATIA)Who this might be right forAdvanced Breast Cancer Spanish Breast Cancer Research Group 32
Testing effectiveness (Phase 2)Study completedNCT03602079What this trial is testingStudy of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneWho this might be right forHER2-positive Breast CancerHER2 Gene MutationHER-2 Gene Amplification+41 more Klus Pharma Inc. 49
Early research (Phase 1)Study completedNCT00849459What this trial is testingGene Therapy in Treating Women With Metastatic Breast CancerWho this might be right forBreast Cancer Max Sung 3
Large-scale testing (Phase 3)Study completedNCT01901146What this trial is testingEfficacy and Safety Study of ABP 980 Compared With Trastuzumab in Women With HER2-positive Early Breast CancerWho this might be right forBreast Cancer Amgen 725
Testing effectiveness (Phase 2)Study completedNCT00317720What this trial is testingTrastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast CancerWho this might be right forBreast CancerNeoplasm Metastasis M.D. Anderson Cancer Center 40
Early research (Phase 1)Study completedNCT01971515What this trial is testingFirst-in-Human Dose Escalation Trial in Subjects With Advanced MalignanciesWho this might be right forSolid Tumor EMD Serono 101
Not applicableActive Not RecruitingNCT07556900What this trial is testingExploring the Potential of Artificial Intelligence for Earlier Breast Cancer Detection: A Retrospective Multi-Reader Study Based on AI-Assisted Mammographic Interpretation (EARLIEST-AI)Who this might be right forBreast CancerAI (Artificial Intelligence)Early Detection of Cancer Mammograaf Radioloogiakliinik 785
Large-scale testing (Phase 3)Study completedNCT02131064What this trial is testingA Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerWho this might be right forBreast Neoplasms Hoffmann-La Roche 444
Testing effectiveness (Phase 2)Looking for participantsNCT04895709What this trial is testingBMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid TumorsWho this might be right forCervical CancerGastric/Gastroesophageal Junction AdenocarcinomaMicrosatellite Stable Colorectal Cancer+8 more Bristol-Myers Squibb 1,109
Large-scale testing (Phase 3)Active Not RecruitingNCT03529110What this trial is testingDS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]Who this might be right forBreast Cancer Daiichi Sankyo 524
Large-scale testing (Phase 3)Study completedNCT01964391What this trial is testingParticipant Satisfaction and Safety With Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 174
Large-scale testing (Phase 3)Looking for participantsNCT05212454What this trial is testingEfficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High RisksWho this might be right forBreast CancerChemotherapy Effect Second Affiliated Hospital, Zhejiang University, School of Medicine 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT02623972What this trial is testingEribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast CancerWho this might be right forInflammatory Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast Dana-Farber Cancer Institute 22
Testing effectiveness (Phase 2)Study completedNCT03272477What this trial is testingStudy to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer PatientsWho this might be right forBreast Neoplasms Palleos Healthcare GmbH 257
Early research (Phase 1)Active Not RecruitingNCT04042701What this trial is testingDS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung CancerWho this might be right forBreast CancerNon-small Cell Lung Carcinoma Daiichi Sankyo 115
Early research (Phase 1)Study completedNCT01761240What this trial is testingDose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLCWho this might be right forBreast CancerPancreatic CancerColorectal Cancer+2 more Morphotek 27